CONMED Corporation CNMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.20% | 66.84% | -17.39% | 485.48% | -86.65% |
| Total Depreciation and Amortization | 0.72% | 1.11% | 6.73% | -5.14% | 0.19% |
| Total Amortization of Deferred Charges | -42.13% | -17.40% | -53.41% | 114.66% | -8.07% |
| Total Other Non-Cash Items | 112.93% | 32.01% | -84.77% | 162.46% | 86.62% |
| Change in Net Operating Assets | 91.21% | 54.14% | -51.73% | -175.12% | 222.61% |
| Cash from Operations | 33.20% | 175.35% | -70.92% | -13.69% | 84.27% |
| Capital Expenditure | 8.52% | -1.45% | 43.42% | 1.47% | 9.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -94.39% | 107.14% | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -116.18% | 181.55% | 157.77% | -37.09% | 9.46% |
| Total Debt Issued | -80.58% | 380.56% | -3.74% | 11.98% | -16.78% |
| Total Debt Repaid | 78.89% | -470.44% | 25.12% | -5.61% | 7.40% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.03% | 83.24% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -0.03% | -0.05% |
| Other Financing Activities | 41.83% | -97.93% | 5.75% | -34.11% | 10.77% |
| Cash from Financing | 20.07% | -105.00% | 39.65% | 14.14% | -64.08% |
| Foreign Exchange rate Adjustments | 147.29% | 84.15% | -2,494.12% | 70.00% | -98.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 363.19% | 139.71% | -406.51% | -62.19% | 422.19% |